EKS SEVEN KLINIKAL RESECH, OOO, Saint Petersburg

Accounting reports

Previously








Share:
Name
EKS SEVEN KLINIKAL RESECH, OOO
INN
7838483013
KPP
780201001
OGRN
1127847624871
OKPO
23188638
Address
194156, G.sankt-peterburg, pr-kt Engel'sa, d. D. 27, of. POMESCH. 50N KOMNATA 28

Extract from EGRUL $12 (€10)

Last name, first name & patronymic of the General Director

List of founders

Position of the company

Licenses

Authorized capital

Branches

Complete structure of the extract
We guarantee to provide you with an actual
information extract

Data on types of economic activities
EKS SEVEN KLINIKAL RESECH, OOO according to EGRUL

OKVED codeTypeName of activity type
86.10Core activityHospitals
72.19Additional activity Research and experimental development on natural sciences and engineering Other
86.21Additional activity General practice
All types of activities
86.22Additional activity Special medical practice
86.90Additional activity Activities in the field of medicine other
87.10Additional activityUniversities, Colleges of public administration
Registration date
16.11.2012

EKS SEVEN KLINIKAL RESECH, OOO (Saint Petersburg; INN 7838483013) was registered on 16 Nov 2012. The company's authorized capital as of July 1, 2012 was 10000 rub.

Principal activities of EKS SEVEN KLINIKAL RESECH, OOO: hospitals (86.10), research and experimental development on natural sciences and engineering other (72.19), general practice (86.21).

Economic indicators

2023

Net profit (RAS) of EKS SEVEN KLINIKAL RESECH, OOO dropped in 2023 by 23.05% to 37.57 million RUB from 48.83 million RUB over the same period in 2022, the company informed.

Revenue decreased in the accounting period by 10.36% to 110.38 million RUB from 123.14 million RUB in 2022.

2022

Net profit (RAS) of EKS SEVEN KLINIKAL RESECH, OOO grew over 2022 2.28 times to 48.83 million RUB from 21.38 million RUB over 2021, the company informed.

Revenue increased in the accounting period 1.74 times to 123.14 million RUB from 70.57 million RUB over 2021.

2021

Net profit (RAS) of EKS SEVEN KLINIKAL RESECH, OOO grew over 2021 1.94 times to 21.38 million RUB from 11.04 million RUB over 2020, the company informed.

Revenue increased in the accounting period 2.08 times to 70.57 million RUB from 33.92 million RUB over 2020.

2020

Net profit (RAS) of EKS SEVEN KLINIKAL RESECH, OOO grew over 2020 6.39 times to 11.04 million RUB from 1.73 million RUB over 2019, the company informed.

Revenue increased in the accounting period by 9.04% to 33.92 million RUB from 31.11 million RUB over 2019.

2018

Net loss (RAS) of EKS SEVEN KLINIKAL RESECH, OOO increased 9.38 times to 7.80 million RUB from 832.00 thousand RUB over 2017, the company informed.

Cost of goods sold grew 8.97 times to 7.30 million RUB from 814.00 thousand RUB; sales loss grew 8.97 times to 7.30 million RUB from 814.00 thousand RUB.

2017




Daily subscription $39 (€32)

unlimited access to database "Kontragent"

download any information within 24 hours

Companies in the region

Guarantees

Guarantees
We guarantee
provision of
relevant
information

Payment methods


Statistics
Companies
12 288 260
Reports
17 430 711
Rrocessed requests
Extract from EGRUL:
Today, 6:45 AM
Accounting reports:
Today, 6:43 AM
The site can contain materials of 16+ category
+7(495) 729−17−96,    info@k-agent.ru
Рейтинг@Mail.ru © "Info-RL", 2006—2024
About the project    Legal basis
Business Business Services Others Info-RL, ООО
Moscow ul. Kazakova, d. 3, str. 4 105064
+7(495) 729−17−96 7 days a week info@k-agent.ru